TransCode Therapeutics
RNAZ
RNAZ
7 hedge funds and large institutions have $186K invested in TransCode Therapeutics in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$47.4K | |
| 2 | +$36K | |
| 3 | +$22.7K | |
| 4 |
SSWM
Sheets Smith Wealth Management
Winston-Salem,
North Carolina
|
+$17K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$3.09K |
Top Sellers
| 1 | -$75.3K | |
| 2 | -$25.6K | |
| 3 | -$24.4K | |
| 4 |
VF
Virtu Financial
New York
|
-$18K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$12.9K |